top
Search terms
Results 21 - 30 of 39 - ordered by :
Pages: 1 2 3 4
Ehjournal

[...]statin treatment also reduced the risk for cardiovascular events and all-cause mortality. See page 1775 for the editorial comment on this article (doi:10.1093/eurheartj/eht124) Introduction In ...

European Heart Journal, Biere-Rafi, Sara, Hutten, Barbara A., Squizzato, Alessandro, Ageno, Walter, Souverein, Patrick C., de Boer, Anton, Gerdes, Victor E.A., Büller, Harry R., Kamphuisen, Pieter ...

Date : 21/06/2013 Item size : 249564 bytes
Romanianjournal

Introduction: In addition to invasive coronary revascularization procedures (PCI) in the treatment of ischemic heart disease indication of a systemic therapy could prevent recurrent events. Aim: The ...

Date : 21/04/2018 Item size : 25253 bytes
Escardio

14:00 P3086 NT-proBNP is a potent prognostic marker in patients with type 2 diabetes hospitalized for acute coronary syndrome - a DIGAMI 2 sub study Ida GUSTAFSSON (Frederiksberg, DK) 14:00 P3087 ...

Poster session 4: Dysglycemia and diabetes

Date : 30/08/2010 Item size : 546829 bytes
Revistaespanola

[...]almost all relevant biological processes implicated in atherogenesis and complicated plaque have been shown to be inhibited by these drugs. [...]in 1994, treatment of patients with ischemic ...

Revista Española de Cardiología

Date : 01/10/2004 Item size : 46735 bytes
Escardio

The original trials in the 1990s that showed the effectiveness of statins in reducing cardiovascular risk in coronary heart disease [1,2] have been followed up by long-term safety and efficacy trials ...

Date : 27/10/2016
Escardio

Peripheral vascular disease is just one manifestation of the general disease process of atherosclerosis. [...]patients with a clinical manifestation of peripheral arterial disease (PAD) are likely ...

Date : 10/12/2004
Escardio

In the prospective Physicians’ Health Study it has been demonstrated that CRP levels predict the risk of cardiovascular events in apparently healthy men and women. Baseline CRP levels have ...

Date : 03/01/2007
Escardio

The data from clinical trials have shown that the elimination of risk factors for atherosclerosis reduces cardiovascular events and improves prognosis - not only in coronary - but also in ...

Date : 14/02/2006
Escardio

Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin ...

Date : 29/08/2016
Escardio

(1) The importance of lowering low-density lipoprotein (LDL) cholesterol is undisputed, with research demonstrating that a decrease of 1 mmol/l (39 mg/dl) could reduce the five year risk of major ...

Date : 26/08/2017